Controlled cell delivery has shown some promising outcomes compared with traditional cell delivery approaches over the past decades, and strategies focused on optimization or engineering of controlled cell delivery have been intensively studied. In this paper, we demonstrate the fabrication of a 3D printed hydrogel scaffold infused with degradable PEGPLA/NB composite hydrogel core for controlled cell delivery with improved cell viability and facile tunability. The 3D printed poly (ethylene glycol) diacrylate (PEGDA) scaffold with specifically designed architectures can provide mechanical support while allowing bidirectional diffusion of small molecules, thus permitting structural integrity and long-term cell viability. Poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA), which is highly susceptible to hydrolysis, however, the acrylation reactions it utilizes for chain growth have been reported as toxic to cells. Poly(ethylene glycol) norbornene (PEGNB), validated for its excellent cytocompatibility, was therefore mixed and infused together with PLA-PEG-PLA into the printed PEGDA scaffold. Cells encapsulated microfluidically into PEGNB microspheres and then polymerized within PEGPLA/NB composite hydrogel maintained excellent viability over a week. Controlled cell release was achieved via the manipulation of PEGPLA/NB composition. By increasing PEGNB proportion in the core, cell release was significantly slowed while increasing PLA-PEG-PLA proportion eventually resulted in a very robust cell release within a short time frame. The functionality of released cells was validated by their cell viability and proliferation potential. In summary, we have shown this droplet-microencapsulation technique coupled with composite degradable hydrogel and 3D printing could offer an alternative route for controlled cell delivery.

Download full-text PDF

Source
http://dx.doi.org/10.1109/TNB.2019.2905510DOI Listing

Publication Analysis

Top Keywords

controlled cell
20
cell delivery
20
cell viability
12
cell release
12
cell
11
pegpla/nb composite
8
composite hydrogel
8
pegda scaffold
8
controlled
6
delivery
5

Similar Publications

Leaky and structurally abnormal blood vessels and increased pressure in the tumor interstitium reduce the infiltration of CAR-T cells in solid tumors, including triple-negative breast cancer (TNBC). Furthermore, high burden of tumor cells may cause reduction of infiltrating CAR-T cells and their functional exhaustion. In this study, various effector-to-target (E:T) ratio experiments are established to model the treatment using CAR-T cells in leukemia (high E:T ratio) and solid tumor (low E:T ratio).

View Article and Find Full Text PDF

Tooth movement is a complex process involving the vascularization of the tissues, remodeling of the bone cells, and periodontal ligament fibroblasts under the hormonal and neuronal regulation mechanisms in response to mechanical force application. Therefore, it will inevitably impact periodontal tissues. Prolonged treatment can lead to adverse effects on teeth and periodontal tissues, prompting the development of various methods to reduce the length of orthodontic treatment.

View Article and Find Full Text PDF

Therapeutic strategy for efficiently targeting cancer cells needs an in-depth understanding of the cellular and molecular interplay in the tumor microenvironment (TME). TME comprises heterogeneous cells clustered together to translate tumor initiation, migration, and proliferation. The TME mainly comprises proliferating tumor cells, stromal cells, blood vessels, lymphatic vessels, cancer-associated fibroblasts (CAFs), extracellular matrix (ECM), and cancer stem cells (CSC).

View Article and Find Full Text PDF

In cancer research and personalized medicine, mesoporous silica nanoparticles (MSNs) have emerged as a significant breakthrough in both cancer treatment and diagnosis. MSNs offer targeted drug delivery, enhancing therapeutic effectiveness while minimizing adverse effects on healthy cells. Due to their unique characteristics, MSNs provide targeted drug delivery, maximizing therapeutic effectiveness with minimal adverse effects on healthy cells.

View Article and Find Full Text PDF

An on-Demand Oxygen Nano-vehicle Sensitizing Protein and Nucleic Acid Drug Augment Immunotherapy.

Adv Mater

January 2025

State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute. Ren Ji Hospital School of Medicine, Shanghai Jiao Tong University, Shanghai, 200032, P. R. China.

Hypoxia severely limits the antitumor immunotherapy for breast cancer. Although efforts to alleviate tumor hypoxia and drug delivery using diverse nanostructures achieve promising results, the creation of a versatile controllable oxygen-releasing nano-platform for co-delivery with immunostimulatory molecules remains a persistent challenge. To address this problem, a versatile oxygen controllable releasing vehicle PFOB@F127@PDA (PFPNPs) is developed, which effectively co-delivered either protein drug lactate oxidase (LOX) or nucleic acids drug unmethylated cytosine-phosphate-guanine oligonucleotide (CpG ODNs).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!